景顺
IVZ
28.20
-0.60
-2.08%
景顺
US · IVZ
#1217 按市值排名
上市于 1970
28.20
-0.60
-2.08%
实时 - 追踪5344个代码 - 心跳于148秒前
· 2026-10-16 20:02
✦ 量化股权信号 计算方式说明
增持
- 机构持股总比例上升了0.2个百分点。
机构持股
- 机构持股比例
- 98.24% +0.19pp
- 机构数量
- 796
- 数据截至
- 2026/Q3 较上一报告期
持股变动 vs 资金流向
方向分歧机构在上一报告期增持了股份,同时该股在最近20个交易日的主力资金呈净流出——两者方向出现分歧。
机构持股变动数据按季度发布且存在滞后;资金流向数据为每日更新。请将其作为方向性的交叉验证参考,而非精确的择时信号。
持股人类型
Mutual Fund60.06%
Private Company20.19%
Hedge Fund10.74%
Public Company3.69%
Government Pension Fund1.59%
Sovereign Wealth Fund1.18%
Individual/Insider0.69%
Family Office/Trust0.33%
Insurance Company0.29%
Other1.23%
主要股东 截至 2026-02-17
Massachusetts Mutual Life Insurance Company
18.44% · 81.41M 股
BlackRock
8.77% · 38.71M 股
Vanguard Capital Management, LLC
6.92% · 30.57M 股
Dimensional Fund Advisors
4.92% · 21.72M 股
Vanguard Portfolio Management, LLC
4.18% · 18.46M 股
State Street Global Advisors
3.80% · 16.79M 股
Millennium Management LLC
3.55% · 15.69M 股
Geode Capital Management, LLC
2.83% · 12.50M 股
AQR Capital Management
2.79% · 12.33M 股
T. Rowe Price Group, Inc.
2.40% · 10.62M 股
条形长度是相对于此处列出的最大股东而言,并非相对于公司100%股权。
内部人持股
共追踪50份申报 · 29次买入 · 21次卖出
| 姓名 | 职务 | 持股比例 |
|---|---|---|
| Massachusetts Mutual Life Insurance Company | -- | 18.44% |
| Andrew Tak Lo | Senior MD & Chief Executive Officer, Asia Pacific | 0.18% |
| Andrew Schlossberg | Chief Executive Officer | 0.17% |
| Laura Dukes | Senior MD & CFO | 0.06% |
| Tony Wong | Senior MD & Co-Head of Investment | 0.03% |
| Jeffrey Kupor | Senior MD & General Counsel | 0.03% |
| G. Wagoner | Chairperson and Non-Executive Director | 0.03% |
| Sarah Beshar | Independent Non-Executive Director | 0.03% |
| Phoebe Wood | Independent Non-Executive Director | 0.02% |
| Nigel Sheinwald | Independent Non-Executive Director | 0.02% |
内部人交易 最近的 Form 4 申报记录
| 日期 | 姓名 | 职务 | 类型 | 股数 | 价格 |
|---|---|---|---|---|---|
| 2026-09-10 | Phoebe Wood | Independent Non-Executive Director | Open Market Disposition | -3,000 | $32.44 |
| 2026-09-08 | Andrew Tak Lo | Senior MD & Chief Executive Officer, Asia Pacific | Open Market Disposition | -143,370 | $32.20–32.85 |
| 2026-09-08 | Andrew Tak Lo | Senior MD & Chief Executive Officer, Asia Pacific | Intent to Sell (Form 144) | -100,840 | $32.20 |
| 2026-09-08 | Stephanie Butcher | Senior MD & Co-Head of Investment | Open Market Disposition | -45,095 | $32.28 |
| 2026-09-07 | Andrew Tak Lo | Senior MD & Chief Executive Officer, Asia Pacific | Intent to Sell (Form 144) | -42,530 | $32.85 |
| 2026-09-03 | Laura Dukes | Senior MD & CFO | Other Disposition | -7,600 | -- |
| 2026-09-03 | Laura Dukes | Senior MD & CFO | Open Market Disposition | -31,075 | $33.16 |
| 2026-08-30 | Stephanie Butcher | Senior MD & Co-Head of Investment | Derivative Exercise and Sale | -30,760 | $32.78 |
| 2026-08-30 | Stephanie Butcher | Senior MD & Co-Head of Investment | Derivative Exercise and Retained | +34,682 | -- |
| 2026-08-30 | Douglas Sharp | Senior MD, Head of EMEA & Americas | Derivative Exercise and Sale | -22,213 | $32.78 |
| 2026-08-30 | Douglas Sharp | Senior MD, Head of EMEA & Americas | Derivative Exercise and Retained | +48,272 | -- |
| 2026-07-01 | Jeffrey Kupor | Senior MD & General Counsel | Sale to Issuer | -26,002 | $27.01 |
| 2026-07-01 | Andrew Tak Lo | Senior MD & Chief Executive Officer, Asia Pacific | Derivative Exercise and Retained | +116,754 | -- |
| 2026-07-01 | Andrew Schlossberg | Chief Executive Officer | Sale to Issuer | -156,007 | $27.01 |
| 2026-07-01 | Laura Dukes | Senior MD & CFO | Sale to Issuer | -52,003 | $27.01 |
| 2026-05-14 | G. Wagoner | Chairperson and Non-Executive Director | Other Acquisition | +8,112 | -- |
| 2026-05-14 | Thomas Finke | Independent Non-Executive Director | Other Acquisition | +8,112 | -- |
| 2026-05-14 | William Glavin | Independent Non-Executive Director | Other Acquisition | +8,112 | -- |
| 2026-05-14 | Phoebe Wood | Independent Non-Executive Director | Other Acquisition | +8,112 | -- |
| 2026-05-14 | Christopher Womack | Non-Executive Director | Other Acquisition | +8,112 | -- |
Form 4 申报记录,每家公司显示最新的一批。"Other Derivative Acquisition"(其他衍生品获取)类目多为限制性股票/期权归属,并非公开市场买入——具体类型见"类型"列。
报价时间 2026-10-16 20:02:13 · 仅供参考,不构成投资建议,也未考虑您的具体情况。
景顺 讨论区 0 条评论